APA (7th ed.) Citation

Babiker, A., Castro nee Green, H., Compagnucci, A., Fiscus, S., Giaquinto, C., Gibb, D., . . . Walker, A. (2011). First-line antiretroviral therapy with a protease inhibitor versus non-nucleoside reverse transcriptase inhibitor and switch at higher versus low viral load in HIV-infected children: An open-label, randomised phase 2/3 trial.

Chicago Style (17th ed.) Citation

Babiker, A., et al. First-line Antiretroviral Therapy with a Protease Inhibitor Versus Non-nucleoside Reverse Transcriptase Inhibitor and Switch at Higher Versus Low Viral Load in HIV-infected Children: An Open-label, Randomised Phase 2/3 Trial. 2011.

MLA (9th ed.) Citation

Babiker, A., et al. First-line Antiretroviral Therapy with a Protease Inhibitor Versus Non-nucleoside Reverse Transcriptase Inhibitor and Switch at Higher Versus Low Viral Load in HIV-infected Children: An Open-label, Randomised Phase 2/3 Trial. 2011.